Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person5
Roivant Sciences Ltd.
Company
Rocket Science Ltd
Company · 05513724
SL Science Holding Ltd
Company
CV Sciences, Inc.
Company
Sight Sciences, Inc.
Company
Primary record20
FMR LLC filed SCHEDULE 13G/A
0000315066-26-002842.txt : 20261105 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0000315066-24-002889 0000315066 XXXXXXXX LIVE 4 COMMON STOCK 09/30/2026 0001635088 ROIVANT SCIENCES LTD G76279101 7TH FLOOR, 50 BR
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-11-05.
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-10-30.
BlackRock, Inc. filed SCHEDULE 13G/A
0002012383-26-003714.txt : 20261027 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0002012383 XXXXXXXX LIVE 1 Common Stock 09/30/2026 0001635088 ROIVANT SCIENCES LTD G76279101 7th Floor 50 Broadway London X0 SW1H
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-10-27.
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-10-27.
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-10-27.
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-10-22.
Roivant Sciences Ltd. filed 8-K
Item 7.01 Regulation FD Disclosure. On October 21, 2026, Roivant Sciences Ltd. (the “Company”) issued a press release announcing positive results from the Phase 3 CLARITY program evaluating brepocitinib in non-infectious
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-10-20.
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-10-20.
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-10-05.
Arbutus Biopharma Corp filed SCHEDULE 13D/A
, as amended, this Amendment No. 14 ("Amendment No. 14") amends certain items of the Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on March 16, 2015, as amended by Amendments No. 1 through 13
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-10-02.
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-10-02.
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-10-02.
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-10-02.
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-09-22.
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-09-22.
Roivant Sciences Ltd. filed 4
SEC form 4 filed by Roivant Sciences Ltd. (CIK 1635088) on 2026-09-18.